Login Register
English
0

Cart

$ 0

Combating atherosclerosis with chirality/phase dual‐engineered nanozyme featuring microenvironment‐programmed senolytic and senomorphic actions.(KTB1040-27.4)

Date:2025-07-25 Views:8